SRPT
Sarepta Therapeutics Inc
Price:  
126.70 
USD
Volume:  
484,703.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SRPT WACC - Weighted Average Cost of Capital

The WACC of Sarepta Therapeutics Inc (SRPT) is 8.0%.

The Cost of Equity of Sarepta Therapeutics Inc (SRPT) is 8.35%.
The Cost of Debt of Sarepta Therapeutics Inc (SRPT) is 4.40%.

Range Selected
Cost of equity 6.90% - 9.80% 8.35%
Tax rate 0.20% - 0.90% 0.55%
Cost of debt 4.00% - 4.80% 4.40%
WACC 6.6% - 9.3% 8.0%
WACC

SRPT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.65 0.88
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 9.80%
Tax rate 0.20% 0.90%
Debt/Equity ratio 0.1 0.1
Cost of debt 4.00% 4.80%
After-tax WACC 6.6% 9.3%
Selected WACC 8.0%